The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostate Cancer Therapeutics Drugs Market Research Report 2025
Synopsis
The global Prostate Cancer Therapeutics Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Therapeutics Drugs.
Report Scope
The Prostate Cancer Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Pfizer, Inc
AstraZeneca
Amgen, Inc
AbbVie, Inc
Bayer AG
Ipsen Group
Sanofi
Endo Pharmaceuticals
Dendreon Corporation
Segment by Type
Hormone Therapy
Chemotherapy
Biologic Therapy
Targeted Therapy
Other
Segment by Sale Channel
Hospital Pharmacy
Retail Pharmacy
Online Sales
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prostate Cancer Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prostate Cancer Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Prostate Cancer Therapeutics Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Therapeutics Drugs.
Report Scope
The Prostate Cancer Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Cancer Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Pfizer, Inc
AstraZeneca
Amgen, Inc
AbbVie, Inc
Bayer AG
Ipsen Group
Sanofi
Endo Pharmaceuticals
Dendreon Corporation
Segment by Type
Hormone Therapy
Chemotherapy
Biologic Therapy
Targeted Therapy
Other
Segment by Sale Channel
Hospital Pharmacy
Retail Pharmacy
Online Sales
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prostate Cancer Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prostate Cancer Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prostate Cancer Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Therapeutics Drugs
1.2 Prostate Cancer Therapeutics Drugs Segment by Type
1.2.1 Global Prostate Cancer Therapeutics Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Hormone Therapy
1.2.3 Chemotherapy
1.2.4 Biologic Therapy
1.2.5 Targeted Therapy
1.2.6 Other
1.3 Prostate Cancer Therapeutics Drugs Segment by Sale Channel
1.3.1 Global Prostate Cancer Therapeutics Drugs Market Value by Sale Channel: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Other
1.4 Global Prostate Cancer Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Therapeutics Drugs Revenue 2019-2030
1.4.2 Global Prostate Cancer Therapeutics Drugs Sales 2019-2030
1.4.3 Global Prostate Cancer Therapeutics Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prostate Cancer Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prostate Cancer Therapeutics Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Prostate Cancer Therapeutics Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostate Cancer Therapeutics Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostate Cancer Therapeutics Drugs, Product Type & Application
2.7 Prostate Cancer Therapeutics Drugs Market Competitive Situation and Trends
2.7.1 Prostate Cancer Therapeutics Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prostate Cancer Therapeutics Drugs Players Market Share by Revenue
2.7.3 Global Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostate Cancer Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Prostate Cancer Therapeutics Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prostate Cancer Therapeutics Drugs Global Prostate Cancer Therapeutics Drugs Sales by Region: 2019-2030
3.2.1 Global Prostate Cancer Therapeutics Drugs Sales by Region: 2019-2024
3.2.2 Global Prostate Cancer Therapeutics Drugs Sales by Region: 2025-2030
3.3 Global Prostate Cancer Therapeutics Drugs Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2019-2030
3.3.1 Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2019-2024
3.3.2 Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2025-2030
3.4 North America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.4.1 North America Prostate Cancer Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prostate Cancer Therapeutics Drugs Sales by Country (2019-2030)
3.4.3 North America Prostate Cancer Therapeutics Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.5.1 Europe Prostate Cancer Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prostate Cancer Therapeutics Drugs Sales by Country (2019-2030)
3.5.3 Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Latin America Prostate Cancer Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2019-2030)
3.7.3 Latin America Prostate Cancer Therapeutics Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prostate Cancer Therapeutics Drugs Sales by Type (2019-2030)
4.1.1 Global Prostate Cancer Therapeutics Drugs Sales by Type (2019-2024)
4.1.2 Global Prostate Cancer Therapeutics Drugs Sales by Type (2025-2030)
4.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2019-2030)
4.2 Global Prostate Cancer Therapeutics Drugs Revenue by Type (2019-2030)
4.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Type (2019-2024)
4.2.2 Global Prostate Cancer Therapeutics Drugs Revenue by Type (2025-2030)
4.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Prostate Cancer Therapeutics Drugs Price by Type (2019-2030)
5 Segment by Sale Channel
5.1 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2019-2030)
5.1.1 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2019-2024)
5.1.2 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2025-2030)
5.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2019-2030)
5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2019-2030)
5.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2019-2024)
5.2.2 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2025-2030)
5.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2019-2030)
5.3 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Corporation Information
6.2.2 Pfizer, Inc Description and Business Overview
6.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.2.5 Pfizer, Inc Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Amgen, Inc
6.4.1 Amgen, Inc Corporation Information
6.4.2 Amgen, Inc Description and Business Overview
6.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.4.5 Amgen, Inc Recent Developments/Updates
6.5 AbbVie, Inc
6.5.1 AbbVie, Inc Corporation Information
6.5.2 AbbVie, Inc Description and Business Overview
6.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.5.5 AbbVie, Inc Recent Developments/Updates
6.6 Bayer AG
6.6.1 Bayer AG Corporation Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Product Portfolio
6.6.5 Bayer AG Recent Developments/Updates
6.7 Ipsen Group
6.6.1 Ipsen Group Corporation Information
6.6.2 Ipsen Group Description and Business Overview
6.6.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ipsen Group Prostate Cancer Therapeutics Drugs Product Portfolio
6.7.5 Ipsen Group Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Prostate Cancer Therapeutics Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Endo Pharmaceuticals
6.9.1 Endo Pharmaceuticals Corporation Information
6.9.2 Endo Pharmaceuticals Description and Business Overview
6.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Portfolio
6.9.5 Endo Pharmaceuticals Recent Developments/Updates
6.10 Dendreon Corporation
6.10.1 Dendreon Corporation Corporation Information
6.10.2 Dendreon Corporation Description and Business Overview
6.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Portfolio
6.10.5 Dendreon Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostate Cancer Therapeutics Drugs Industry Chain Analysis
7.2 Prostate Cancer Therapeutics Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostate Cancer Therapeutics Drugs Production Mode & Process
7.4 Prostate Cancer Therapeutics Drugs Sales and Marketing
7.4.1 Prostate Cancer Therapeutics Drugs Sales Channels
7.4.2 Prostate Cancer Therapeutics Drugs Distributors
7.5 Prostate Cancer Therapeutics Drugs Customers
8 Prostate Cancer Therapeutics Drugs Market Dynamics
8.1 Prostate Cancer Therapeutics Drugs Industry Trends
8.2 Prostate Cancer Therapeutics Drugs Market Drivers
8.3 Prostate Cancer Therapeutics Drugs Market Challenges
8.4 Prostate Cancer Therapeutics Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
